Stock Market News

Merck in late-stage talks to acquire Prometheus Biosciences -WSJ

04/16/2023
Less than a minute

2023.04.16 00:54


© Reuters. FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly

(Reuters) – Merck & Co is in late-stage talks to acquire Prometheus Biosciences Inc to get its hands on promising immune disease treatments, the Wall Street Journal reported on Sunday citing people familiar with the matter.

Source link

04/16/2023
Less than a minute

Related Articles

Nio Stock Price Target Cut at Deutsche Bank as 2H Estimates ‘Clearly Need to Come Down’

Nio Stock Price Target Cut at Deutsche Bank as 2H Estimates ‘Clearly Need to Come Down’

08/29/2022
Fortis shows resilience with sixfold stock rise since Y2K and 50-year dividend growth

Fortis shows resilience with sixfold stock rise since Y2K and 50-year dividend growth

11/25/2023

Reddit stock rises after-hours on talk of new ad import feature from Meta

01/28/2025
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.74%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.74%

08/25/2023
Back to top button